TCR Repertoire Analysis Reveals Mobilization of Novel CD8+ T Cell Clones Into the Cancer-Immunity Cycle Following Anti-CD4 Antibody Administration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TCR Repertoire Analysis Reveals Mobilization of Novel CD8+ T Cell Clones Into the Cancer-Immunity Cycle Following Anti-CD4 Antibody Administration

Published:2019-01-24 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Aoki Hiroyasu,Ueha Satoshi,Shichino Shigeyuki,Ogiwara Haru,Hashimoto Shin-ichi,Kakimi Kazuhiro,Ito Satoru,Matsushima Kouji

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference29 articles.

1. Nivolumab versus docetaxel in advanced squamous-cell non–small-cell lung cancer;Brahmer;N Engl J Med.,2015

2. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med.,2015

3. Nivolumab versus Everolimus in advanced renal-cell carcinoma;Motzer;N Engl J Med.,2015

4. Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy;Choi;Cancer Res.,2007

5. Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors;Yu;J Exp Med.,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD8+ T cell priming that is required for curative intratumorally anchored anti-4-1BB immunotherapy is constrained by Tregs;Nature Communications;2024-03-01

2. Tregs constrain CD8⁺T cell priming required for curative intratumorally anchored anti-4-1BB immunotherapy;2023-02-01

3. Immunotherapy in Gastrointestinal Cancer Focusing on CAR-T Cell Therapy;Interdisciplinary Cancer Research;2023

4. Identification of Highly Cross-Reactive Mimotopes for a Public T Cell Response in Murine Melanoma;Frontiers in Immunology;2022-06-23

5. Identification of highly cross-reactive mimotopes for a public T cell response in murine melanoma;2022-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3